Tag: regulatory science

IVIVC and Waivers: How In Vitro Methods Are Replacing In Vivo Bioequivalence Testing

IVIVC and Waivers: How In Vitro Methods Are Replacing In Vivo Bioequivalence Testing

| 11:20 AM | 0

IVIVC lets pharmaceutical companies predict how a drug behaves in the body using lab-based dissolution tests, replacing costly and time-consuming human trials. When done right, it saves millions and speeds up generic drug approval.

read more